-
Navigating Mental Health Without Drugs
19 Mar 2025 00:07 GMT
… Depakote and Prozac.
The crises multiplied. So did the diagnoses and drugs … off the drugs, without clear guidance from doctors, new … A Story of Psychiatric Treatment Resistance, which will be … on psychiatric medication? How has the pharmaceutical industry shaped …
-
FDA Approved Drug Products Approval List January 2025
11 Mar 2025 11:43 GMT
Approval Date Drug Name Submission Active Ingredients Company … 01/23/2025 DEPAKOTE ERNDA #021168 SUPPL-48 DIVALPROEX … #761036 SUPPL-51 DARATUMUMAB JANSSEN BIOTECH Approval 01/24…
-
Tales of Overconfidence: 3 Stories to Refine Psychiatry
09 Apr 2025 19:54 GMT
… The DSM-5 field trials, with their inter … medical practice crumble and family ties weaken—and his requests for antidepressants … and boosting biochemical treatments. It remains a … and 19 different psychiatric drugs, including Depakote, Seroquel, Klonopin, …
-
Epilepsy Drugs Market to Worth USD 10.9 Billion by 2032, Driven by Innovation & Rising Prevalence – SNS Insider
13 Feb 2025 11:15 GMT
… to treatments, advanced epilepsy medications are … Depakote, Trileptal)
• Johnson & Johnson - (Topamax, Invega)
• Teva Pharmaceuticals … like the FDA, that support … Drugs Market by Product
8. Epilepsy Drugs Market by Drugs Type
9. Epilepsy Drugs …
-
Understanding Epilepsy: Causes, Symptoms, Diagnosis and Treatment
29 Jan 2025 04:16 GMT
… epileptic ( anticonvulsant, antiseizure) drug
ketogenic diet
Vagus Nerve Stimulator … the ight treatment for your condition.
Medications for epilepsy … medication include:
Topiramate (Topamax)
lamotrigine (lamictal)
levetiracetam (keppra)
valproic acid (Depakote …
-
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
07 Jan 2025 11:50 GMT
… with high unmet medical need, including epilepsy … drugs for a range of CNS indications, including Depakote, Depakote … developed epilepsy drugs, including Spinifex Pharmaceuticals, which was … a biotechnology company developing innovative treatments for …
-
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
22 Dec 2024 20:05 GMT
Alembic Pharmaceuticals Limited (Alembic) announced … ) for its Abbreviated New Drug Application (ANDA) Divalproex Sodium … the reference listed drug product (RLD), Depakote Sprinkle Capsules, 125 … USFDA.
Shares of Alembic Pharmaceuticals Limited was last trading …
-
USFDA gives nod to Alembic Pharma’s anti-epileptic drug
20 Dec 2024 10:11 GMT
Alembic Pharmaceuticals Limited on Friday announced … USFDA) for its Abbreviated New Drug Application (ANDA) Divalproex Sodium … to the reference listed drug product (RLD), Depakote Sprinkle Capsules, 125 … is an anti-epileptic drug indicated for monotherapy and …
-
Alembic Pharmaceuticals secures USFDA approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
20 Dec 2024 09:58 GMT
… for its Abbreviated New Drug Application (ANDA) for … a generic version of Depakote Sprinkle Capsules, 125 … critical role in epilepsy treatment.
Market Opportunity: Divalproex … Alembic Pharmaceuticals: Established in 1907, Alembic Pharmaceuticals Limited has …
-
Alembic Pharmaceuticals shares surge nearly 3% on USFDA approval for Divalproex Sodium Capsules
20 Dec 2024 09:58 GMT
Shares of Alembic Pharmaceuticals saw a sharp … Depakote Sprinkle Capsules by AbbVie Inc.
Market Size: The drug … position in the global pharmaceutical market.
Day
Open
Close …
About Alembic Pharmaceuticals:
Established in 1907, Alembic Pharmaceuticals Limited is …